A novel mutant from apoptosis-resistant colon cancer HT-29 cells showing hyper-apoptotic response to hypoxia, low glucose and cisplatin

Japanese Journal of Cancer Research

Volumn 89, Issue 11, 1998, Pages 1169-1178

  Suzuki, Hiroyuki ^a   Tomida, Akihiro ^a   Tsuruo, Takashi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

Apoptosis; Cisplatin; Fas; Glucose regulated stress; Hypoxia

Indexed keywords

CASPASE 3; CISPLATIN; GLUCOSAMINE; GLUCOSE; TUNICAMYCIN;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL MUTANT; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HYPOXIA; PHENOTYPE; PRIORITY JOURNAL;

EID: 0032444682     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00512.x     Document Type: Article

References (26)

1. Sutherland, R. M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science, 240, 177-184 (1988).
2. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med., 3, 177-182 (1997).
3. Lee, A. S. Coordinated regulation of a set of genes by glucose and calcium ionophores in mammalian cells. Trends Biocliem. Sci., 12, 20-23 (1987).
4. Welch, W. J. The mammalian stress response: cell physiology and biochemistry of stress proteins. In "Stress Proteins in Biology and Medicine," ed. R. I. Morimoto, A. Tissieres and C. Georgopoulos, pp. 223-278 (1990). Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
5. Shen, J., Hughes, C., Chao, C., Cai, J., Bartels, C., Gessner, T. andSubjeck, J. Coinduction of glucose-regulated proteins and doxorubicin resistance in Chinese hamster cells. Proc. Natl. Acad. Sci. USA, 84, 3278-3282 (1987).
6. Hughes, C. S., Shen, J. W. andSubjeck, J. R. Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells. Cancer Res., 49, 4452-4454 (1989).
7. Yun, J., Tomida, A., Nagata, K. andTsuruo, T. Glucose-regulated stresses confer resistance to VP-16 in human cancer cells through a decreased expression of DNA topoisomerase II. Oncol. Res., 7, 583-590 (1995).
8. Tomida, A., Yun, J. andTsuruo, T. Glucose-regulated stresses induce resistance to camptothecin in human cancer cells. Int. J. Cancer, 68, 391-396 (1996).
9. Hockel, M., Schienger, K., Aral, B., Mitze, M., Schaffer, U. andVaupel, P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res., 56, 4509-4515 (1996).
10. Blank, K. R., Rudoltz, M. S. Kao, G. D., Muschel, R. J. andMcKenna, W. G. The molecular regulation of apoptosis and implications for radiation Sncology. Int. J. Radiat. Biol, 71, 455-466 (1997).
11. Kaufmann, S. H. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res., 49, 5870-5878 (1989).
12. Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W. andGiaccia, A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 379, 88-91 (1996).
13. Shim, H., Chun, Y. S., Lewis, B. C. andDang, C. V. A unique glucose-dependent apoptotic pathway induced by c-Myc. Proc. Natl. Acad. Sci. USA, 95, 1511-1516 (1998).
14. Graeber, T. G., Peterson, J. F., Tsai, M., Monica, K., Fornace, A. J., Jr. andGiaccia, A. J. Hypoxia induces accumulation of p53 protein, but activation of a Gl-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol., 14, 6264-6277 (1994).
15. Tomida, A., Suzuki, H., Kim, H. D. andTsuruo, T. Glucose-regulated stresses cause decreased expression of cyclin D1 and hypophosphorylation of retinoblastoma protein in human cancer cells. Oncogene, 13, 2699-2705 (1996).
16. Krtolica, A. andLudlow, J. W. Hypoxia arrests ovarian carcinoma cell cycle progression, but invasion is unaffected. Cancer Res., 56, 1168-1173 (1996).
17. Sinicrope, F. A., Ruan, S. B., Cleary, K. R., Stephens, L. C., Lee, J. J. andLevin, B. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res., 55, 237-241 (1995).
18. Ko, L. J. andPrives, C. p53: puzzle and paradigm. Genes Dev., 10, 1054-1072 (1996).
19. Naik, P., Karrim, J. andHanahan, D. The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev., 10, 2105-2116 (1996).
20. Shimizu, S., Eguchi, Y., Kosaka, H., Kamiike, W., Matsuda, H. andTsujimoto, Y. Prevention of hypoxia-induced cell death by Bcl-2 and Bel-XL. Nature, 374, 811-813 (1995).
21. Shimizu, S., Eguchi, Y., Kamiike, W., Itoh, Y., Hasegawa, J., Yamabe, K., Otsuki, Y., Matsuda, H. andTsujimoto, Y. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bel-XL. Cancer Res., 56, 2161-2166 (1996).
22. Reed, J. C., Miyashita, T., Takayama, S., Wang, H. G., Sato, T., Krajewski, S., Aime-Sempe, C., Bodrug, S., Kitada, S. andHanada, M. Bcl-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J. Cell. Biochem., 60, 23-32 (1996).
23. Aas, T., Borresen, A. L., Geisler, S., Smith-Sorensen, B., Johnsen, H., Varhaug, J. E., Akslen, L. A. andLonning, P. E. Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nat. Med., 2, 811-814 (1996).
24. Tomida, A., Naito, M. andTsuruo, T. Acute induction of adriamycin-resistance in human colon carcinoma HT-29 cells exposed to a sublethal dose of adriamycin. Jpn. J. Cancer Res., 86, 224-232 (1995).
25. Gottesman, M. M. Chinese hamster ovary cells. Methods Enzymol., 151, 3-8 (1987).
26. Elbein, A. D. Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains. Annu. Rev. Biochem., 56, 497-534 (1987).